An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Clinical Review Report: Dexamethasone (Ozurdex): (Allergan Inc.): Indication: For the treatment of adult patients with diabetic macular edema who are pseudophakic [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Nov.
Top results in this bookTable of Contents
Pharmacoeconomic Review Report: Dexamethasone (Ozurdex): (Allergan Inc.): Indication: For the treatment of adult patients with diabetic macular edema who are pseudophakic [Internet].
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
Cataracts in adults: management.
London: National Institute for Health and Care Excellence (NICE); 2017 Oct. (NICE Guideline, No. 77.)
The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation.
Frampton G, Harris P, Cooper K, et al.
Southampton (UK): NIHR Journals Library; 2014 Nov. (Health Technology Assessment, No. 18.68.)
CADTH Canadian Drug Expert Committee Recommendation: Dexamethasone (Ozurdex — Allergan Canada Inc.): Indication: For the treatment of adult patients with diabetic macular edema who are pseudophakic [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Oct.
Intraocular Lenses for Infants With Aphakia: CADTH Health Technology Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Feb.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Intraocular Lenses for Cataract Surgery: CADTH Health Technology Review [Internet].
Hamel C, Bailey S; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Nov.
Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
Elwenspoek MMC, Thom H, Sheppard AL, et al.
Southampton (UK): National Institute for Health and Care Research; 2022 Oct. (Health Technology Assessment, No. 26.44.)
Dexamethasone Intravitreal Implant (Ozurdex): CADTH Reimbursement Review: Therapeutic area: Diabetic macular edema [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar.
Evidence reviews for the effectiveness of lipid modification therapies and antihypertensive medicines: Diabetic retinopathy: management and monitoring: Evidence review D.
London: National Institute for Health and Care Excellence (NICE); 2024 Aug. (NICE Guideline, No. 242.)
Intravitreal aflibercept compared with panretinal photocoagulation for proliferative diabetic retinopathy: the CLARITY non-inferiority RCT.
Sivaprasad S, Hykin P, Prevost AT, et al.
Southampton (UK): NIHR Journals Library; 2018 Oct. (Efficacy and Mechanism Evaluation, No. 5.5.)
The Prevalence of Visual Impairment in People with Dementia (the PrOVIDe study): a cross-sectional study of people aged 60–89 years with dementia and qualitative exploration of individual, carer and professional perspectives.
Bowen M, Edgar DF, Hancock B, et al.
Southampton (UK): NIHR Journals Library; 2016 Jul. (Health Services and Delivery Research, No. 4.21.)
Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review.
Waugh N, Loveman E, Colquitt J, et al.
Southampton (UK): NIHR Journals Library; 2018 May. (Health Technology Assessment, No. 22.27.)
Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
Gazzard G, Konstantakopoulou E, Garway-Heath D, et al.
Southampton (UK): NIHR Journals Library; 2019 Jun. (Health Technology Assessment, No. 23.31.)
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.
Hykin P, Prevost AT, Sivaprasad S, et al.
Southampton (UK): NIHR Journals Library; 2021 Jun. (Health Technology Assessment, No. 25.38.)
Aflibercept 8 mg (0.07 mL) (Eylea HD): Therapeutic area: Macular degeneration, age-related: Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Nov.
Making Eye Health a Population Health Imperative: Vision for Tomorrow.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on Public Health Approaches to Reduce Vision Impairment and Promote Eye Health; Welp A, Woodbury RB, McCoy MA, et al., editors.
Washington (DC): National Academies Press (US); 2016 Sep 15.
Dexamethasone Intravitreal Implant (Ozurdex): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with diabetic macular edema who are pseudophakic and have had an inadequate response to prior anti–vascular endothelial growth factor therapy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Jan.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on